Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells.

Tamzalit F, Barbieux I, Plet A, Heim J, Nedellec S, Morisseau S, Jacques Y, Mortier E.

Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8565-70. doi: 10.1073/pnas.1405514111. Epub 2014 May 27.

2.

Interactive quantum chemistry: a divide-and-conquer ASED-MO method.

Bosson M, Richard C, Plet A, Grudinin S, Redon S.

J Comput Chem. 2012 Mar 15;33(7):779-90. doi: 10.1002/jcc.22905. Epub 2012 Jan 7.

PMID:
22228556
3.

Autonomous and extrinsic regulation of thymopoiesis in human immune system (HIS) mice.

Huntington ND, Alves NL, Legrand N, Lim A, Strick-Marchand H, Plet A, Weijer K, Jacques Y, Spits H, Di Santo JP.

Eur J Immunol. 2011 Oct;41(10):2883-93. doi: 10.1002/eji.201141586. Epub 2011 Aug 30.

4.

Despite an impaired response to IL-7, CD4+EM T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI.

Pacheco Y, Solé V, Billaud E, Allavena C, Plet A, Ferré V, Garrigue-Antar L, Raffi F, Jacques Y, McIlroy D.

AIDS. 2011 Sep 10;25(14):1701-10. doi: 10.1097/QAD.0b013e328349a437.

PMID:
21673554
5.

IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo.

Huntington ND, Alves NL, Legrand N, Lim A, Strick-Marchand H, Mention JJ, Plet A, Weijer K, Jacques Y, Becker PD, Guzman C, Soussan P, Kremsdorf D, Spits H, Di Santo JP.

Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6217-22. doi: 10.1073/pnas.1019167108. Epub 2011 Mar 28.

6.

Different dynamics of IL-15R activation following IL-15 cis- or trans-presentation.

Perdreau H, Mortier E, Bouchaud G, Solé V, Boublik Y, Plet A, Jacques Y.

Eur Cytokine Netw. 2010 Dec;21(4):297-307. doi: 10.1684/ecn.2010.0207. Epub 2010 Nov 16.

7.

Interleukin-15 and its soluble receptor mediate the response to infliximab in patients with Crohn's disease.

Bouchaud G, Mortier E, Flamant M, Barbieux I, Plet A, Galmiche JP, Jacques Y, Bourreille A.

Gastroenterology. 2010 Jun;138(7):2378-87. doi: 10.1053/j.gastro.2010.02.044. Epub 2010 Feb 23.

PMID:
20188102
8.

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.

Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A, Corcuff E, Mortier E, Jacques Y, Spits H, Di Santo JP.

J Exp Med. 2009 Jan 16;206(1):25-34. doi: 10.1084/jem.20082013. Epub 2008 Dec 22.

9.

The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha.

Bouchaud G, Garrigue-Antar L, Solé V, Quéméner A, Boublik Y, Mortier E, Perdreau H, Jacques Y, Plet A.

J Mol Biol. 2008 Sep 26;382(1):1-12. doi: 10.1016/j.jmb.2008.07.019. Epub 2008 Jul 16.

PMID:
18656487
10.

The soluble alpha chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer.

Badoual C, Bouchaud G, Agueznay Nel H, Mortier E, Hans S, Gey A, Fernani F, Peyrard S, -Puig PL, Bruneval P, Sastre X, Plet A, Garrigue-Antar L, Quintin-Colonna F, Fridman WH, Brasnu D, Jacques Y, Tartour E.

Cancer Res. 2008 May 15;68(10):3907-14. doi: 10.1158/0008-5472.CAN-07-6842.

11.

Docking of human interleukin-15 to its specific receptor alpha chain: correlation between molecular modeling and mutagenesis experimental data.

Quéméner A, Bernard J, Mortier E, Plet A, Jacques Y, Tran V.

Proteins. 2006 Nov 15;65(3):623-36.

PMID:
17001647
12.

Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins.

Mortier E, Quéméner A, Vusio P, Lorenzen I, Boublik Y, Grötzinger J, Plet A, Jacques Y.

J Biol Chem. 2006 Jan 20;281(3):1612-9. Epub 2005 Nov 11.

13.
14.

Identification of an interleukin-15alpha receptor-binding site on human interleukin-15.

Bernard J, Harb C, Mortier E, Quéméner A, Meloen RH, Vermot-Desroches C, Wijdeness J, van Dijken P, Grötzinger J, Slootstra JW, Plet A, Jacques Y.

J Biol Chem. 2004 Jun 4;279(23):24313-22. Epub 2004 Mar 23.

15.

Polypyrimidine tract-binding protein represses splicing of a fibroblast growth factor receptor-2 gene alternative exon through exon sequences.

Le Guiner C, Plet A, Galiana D, Gesnel MC, Del Gatto-Konczak F, Breathnach R.

J Biol Chem. 2001 Nov 23;276(47):43677-87. Epub 2001 Sep 13.

16.

Anchorage-dependent expression of cyclin A in primary cells requires a negative DNA regulatory element and a functional Rb.

Philips A, Huet X, Plet A, Rech J, Vié A, Blanchard JM.

Oncogene. 1999 Mar 11;18(10):1819-25.

17.

[Cyclin A: a good markers for the study of cell cycle control and tumor progression?].

Philips A, Huet X, Plet A, Rech J, Vignais ML, Vié A, Blanchard JM.

C R Seances Soc Biol Fil. 1998;192(2):223-30. Review. French.

PMID:
9759365
18.

The retinoblastoma protein is essential for cyclin A repression in quiescent cells.

Philips A, Huet X, Plet A, Le Cam L, Vié A, Blanchard JM.

Oncogene. 1998 Mar;16(11):1373-81.

19.

Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon.

Del Gatto F, Plet A, Gesnel MC, Fort C, Breathnach R.

Mol Cell Biol. 1997 Sep;17(9):5106-16.

20.

Relief of cyclin A gene transcriptional inhibition during activation of human primary T lymphocytes via CD2 and CD28 adhesion molecules.

Plet A, Huet X, Algarté M, Rech J, Imbert J, Philips A, Blanchard JM.

Oncogene. 1997 May 29;14(21):2575-83.

21.

Cyclin A expression is under negative transcriptional control during the cell cycle.

Huet X, Rech J, Plet A, Vié A, Blanchard JM.

Mol Cell Biol. 1996 Jul;16(7):3789-98.

22.
23.

TGF-beta 1 and cAMP attenuate cyclin A gene transcription via a cAMP responsive element through independent pathways.

Barlat I, Henglein B, Plet A, Lamb N, Fernandez A, McKenzie F, Pouysségur J, Vié A, Blanchard JM.

Oncogene. 1995 Oct 5;11(7):1309-18.

PMID:
7478551
24.
25.

Chromosomal location and expression of the genes coding for Ku p70 and p80 in human cell lines and normal tissues.

Cai QQ, Plet A, Imbert J, Lafage-Pochitaloff M, Cerdan C, Blanchard JM.

Cytogenet Cell Genet. 1994;65(4):221-7.

PMID:
8258294
26.

In vivo footprints between the murine c-myc P1 and P2 promoters.

Plet A, Tourkine N, Mechti N, Jeanteur P, Blanchard JM.

Oncogene. 1992 Sep;7(9):1847-51.

PMID:
1501892
28.

Retinoic acid-induced rapid loss of nuclear cyclic AMP-dependent protein kinase in teratocarcinoma cells.

Plet A, Evain-Brion D, Gerbaud P, Anderson WB.

Cancer Res. 1987 Nov 15;47(22):5831-4.

29.

Deficiency of cyclic AMP-dependent protein kinases in human psoriasis.

Brion DE, Raynaud F, Plet A, Laurent P, Leduc B, Anderson W.

Proc Natl Acad Sci U S A. 1986 Jul;83(14):5272-6.

30.

Retinoic acid effect on cyclic AMP-dependent protein kinases in embryonal carcinoma cells: studies with differentiation-defective sublines.

Plet A, Gerbaud P, Sherman MI, Anderson WB, Brion DE.

J Cell Physiol. 1986 May;127(2):341-7.

PMID:
3700486
32.
33.

[Relationships between growth, and plasma growth hormone and growth factors under normal physiological conditions and during pathological states (author's transl)].

Schimpff RM, Donnadieu M, Garnier PE, Plet A, Thieriot G, Martinez MJ, Chaussain JL, Job JC.

Ann Endocrinol (Paris). 1980 Nov-Dec;41(6):512-21. Review. French.

PMID:
7018377
34.

The relative contribution of somatomedin to the serum-stimulated growth of human fibroblasts.

Plet A, Berwald-Netter Y.

Biochem Biophys Res Commun. 1980 Jun 16;94(3):744-54. No abstract available.

PMID:
6772180
35.

Leprechaunism: studies of the relationship among hyperinsulinism, insulin resistance, and growth retardation.

D'Ercole AJ, Underwood LE, Groelke J, Plet A.

J Clin Endocrinol Metab. 1979 Mar;48(3):495-502. No abstract available.

PMID:
570979
36.

Determination of human serum somatomedin activity in rabbit articular chondrocytes isolated and incubated in vitro-a critical study.

Binet E, Plet A, Calzada LD.

Biomedicine. 1979 Feb;30(1):31-40. No abstract available.

PMID:
465639
37.

The somatomedin group of peptide growth factors.

Van Wyk JJ, Furlanetto RW, Plet AS, D'Ercole AJ, Underwood LE.

Natl Cancer Inst Monogr. 1978 May;(48):141-7.

PMID:
748748

Supplemental Content

Support Center